Put Options

12 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

May 16, 2022

SELL
$28.19 - $46.6 $360,832 - $596,480
-12,800 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$41.2 - $73.6 $325,480 - $581,440
7,900 Added 161.22%
12,800 $579,000
Q3 2021

Nov 12, 2021

BUY
$59.15 - $91.99 $289,835 - $450,751
4,900 New
4,900 $297,000
Q2 2021

Aug 06, 2021

SELL
$63.02 - $95.11 $535,670 - $808,435
-8,500 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$57.62 - $95.6 $265,052 - $439,760
4,600 Added 117.95%
8,500 $535,000
Q4 2020

Feb 12, 2021

SELL
$41.43 - $77.09 $691,881 - $1.29 Million
-16,700 Reduced 81.07%
3,900 $292,000
Q4 2019

Feb 12, 2020

SELL
$19.24 - $28.41 $115,439 - $170,460
-6,000 Reduced 22.56%
20,600 $432,000
Q3 2019

Nov 14, 2019

BUY
$20.03 - $40.08 $388,582 - $777,552
19,400 Added 269.44%
26,600 $581,000
Q2 2019

Aug 20, 2019

BUY
$25.78 - $39.77 $185,616 - $286,344
7,200 New
7,200 $259,000
Q1 2019

May 15, 2019

SELL
$22.09 - $39.21 $340,186 - $603,834
-15,400 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$19.89 - $30.02 $600,678 - $906,604
-30,200 Reduced 66.23%
15,400 $362,000
Q3 2018

Nov 14, 2018

BUY
$12.1 - $28.85 $551,760 - $1.32 Million
45,600 New
45,600 $1.32 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.34B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.